TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01652573 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT01906580 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03179956 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT01019200 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03339219 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01279785 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT01279785 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04009733 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study NCT04009733 — Predictive Biomarker (PRD): COL1A2 mRNA
Genes: COL1A2
Study NCT00074490 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02313779 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02458807 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01047553 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01179737 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01179737 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03437616 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02799680 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT00983632 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00112281 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00302367 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT00126724 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00340873 — Predictive Biomarker (PRD): CYP1A1 mRNA
Genes: CYP1A1
Study NCT00935558 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00935558 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02767063 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02767063 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03371797 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03130790 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03130790 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03130790 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT03130790 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02254954 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT00405743 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00771329 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study NCT02013856 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02865473 — Predictive Biomarker (PRD): PHEX mRNA
Genes: PHEX; PEX
Study NCT00249899 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00249899 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00388817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00511355 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00511355 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT00511355 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT00969670 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT00030342 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00030342 — Safety Biomarker (SAF): Interleukin 12
Study NCT03360630 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00005783 — Predictive Biomarker (PRD): KITLG mRNA
Genes: KITLG; MGF; SCF
Study NCT00005783 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03601286 — Predictive Biomarker (PRD): IL2RG mRNA
Genes: IL2RG
Study NCT03601286 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01324414 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study NCT00124553 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00213785 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT00213785 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT03084640 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04664699 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01849861 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT04642014 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00147524 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00002778 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00490568 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT00811486 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT04121442 — Safety Biomarker (SAF): Interleukin 1
Study NCT03743675 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03232515 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001550 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study NCT00692263 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00005232 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04275622 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02923297 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT00309491 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02332343 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03927105 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01514682 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05562986 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study NCT02805829 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01863511 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01272141 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01272141 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00663182 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03368261 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT00379431 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02072590 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT03033186 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03424759 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03424759 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02474290 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02780128 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT04358679 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02783456 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01956461 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00295620 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02163694 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02163694 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00462813 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00713167 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00713167 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02022982 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT02022982 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04461990 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04461990 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02513329 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03140605 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT03140605 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04205344 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03619551 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02833467 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00631085 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00539695 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00539695 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT04323657 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01136083 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05287009 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01708759 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT00626938 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01799915 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT01799915 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01558661 — Predictive Biomarker (PRD): MYB mRNA
Genes: MYB
Study NCT01270386 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04344678 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04344678 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): VGF mRNA
Genes: VGF
Study NCT01956916 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03705715 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT02586649 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT01017107 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT00004669 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00155896 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00155896 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00006314 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01742117 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02315872 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01994824 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT01994824 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02136069 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00726466 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00726466 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT05786092 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02961829 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00191451 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03906786 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03110770 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03458195 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03458195 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03458195 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01179113 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02653222 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03556839 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04713436 — Predictive Biomarker (PRD): DSPP mRNA
Genes: DSPP
Study NCT04713436 — Predictive Biomarker (PRD): ALPP mRNA
Genes: ALPP; PLAP
Study NCT04127006 — Predictive Biomarker (PRD): EYS mRNA
Genes: EYS; C6orf178; C6orf179; C6orf180; EGFL10; EGFL11; SPAM; UNQ9424/PRO34591
Study NCT02432859 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05119387 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00495651 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02217566 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT04762628 — Predictive Biomarker (PRD): MAF mRNA
Genes: MAF
Study NCT04395911 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00258921 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01437566 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT00868881 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01381159 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04484974 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04484974 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04859582 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04859582 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00301639 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT00617968 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00323557 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01541670 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT03346980 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT03346980 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04344561 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00993330 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03001817 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00176761 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00176761 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02835079 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02103530 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT01075373 — Predictive Biomarker (PRD): DISC1 mRNA
Genes: DISC1; KIAA0457
Study NCT01075373 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study NCT01075373 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study NCT01075373 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT01075373 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT01075373 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study NCT02758444 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study NCT01048034 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01733680 — Predictive Biomarker (PRD): SLC9A9 mRNA
Genes: SLC9A9; NHE9; Nbla00118
Study NCT01315262 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT01315262 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT01391533 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02100696 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03400722 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01651403 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00339196 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00080899 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT01260532 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT01260532 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study NCT01260532 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT01260532 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study NCT01260532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00173849 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT01818674 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00684515 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04145232 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04145232 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00492128 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03789058 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00720460 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00743938 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02417584 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03285425 — Predictive Biomarker (PRD): CLN6 mRNA
Genes: CLN6
Study NCT00006033 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00530439 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01570569 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT01570569 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01570569 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01570569 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01658449 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00859703 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04507984 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04236258 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02272686 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT01396070 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01960894 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00504959 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00983047 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00983047 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03370497 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03370497 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT02095743 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02053376 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02053376 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01742286 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02400385 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT00000921 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00751868 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00217178 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00441857 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT03233854 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03233854 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT00017862 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT00017862 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01490489 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03706287 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03706287 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03706287 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03706287 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT04059588 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT03329937 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03329937 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04517175 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT00003280 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04170595 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04170595 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT02258360 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00709007 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04106362 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03718143 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study NCT00132470 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01512511 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00990704 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT01465126 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00004661 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02476539 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02476539 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03056508 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03056508 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03056508 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03056508 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03204734 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03204734 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03204734 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04753398 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00360659 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00005601 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20